Matches in SemOpenAlex for { <https://semopenalex.org/work/W2052539116> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2052539116 endingPage "360" @default.
- W2052539116 startingPage "349" @default.
- W2052539116 abstract "Objective: This retrospective analysis assessed the capability of active and passive safety surveillance systems to track product-specific safety events in the USA for branded and generic enoxaparin, a complex injectable subject to immune-related and other adverse events (AEs).Methods: Analysis of heparin-induced thrombocytopenia (HIT) incidence was performed on benefit claims for commercial and Medicare supplemental-insured individuals newly treated with enoxaparin under pharmacy benefit (1 January 2009 – 30 June 2012). Additionally, spontaneous reports from the FDA AE Reporting System were reviewed to identify incidence and attribution of enoxaparin-related reports to specific manufacturers.Results: Specific, dispensed products were identifiable from National Drug Codes only in pharmacy-benefit databases, permitting sensitive comparison of HIT incidence in nearly a third of patients treated with brand or generic enoxaparin. After originator medicine’s loss of exclusivity, only 5% of spontaneous reports were processed by generic manufacturers; reports attributable to specific generics were approximately ninefold lower than expected based on market share.Conclusions: Claims data were useful for active surveillance of enoxaparin generics dispensed under pharmacy benefits but not for products administered under medical benefits. These findings suggest that the current spontaneous reporting system will not distinguish product-specific safety signals for products distributed by multiple manufacturers, including biosimilars." @default.
- W2052539116 created "2016-06-24" @default.
- W2052539116 creator A5002529159 @default.
- W2052539116 creator A5016491016 @default.
- W2052539116 creator A5046569565 @default.
- W2052539116 creator A5063496464 @default.
- W2052539116 creator A5078134055 @default.
- W2052539116 creator A5091660415 @default.
- W2052539116 date "2015-01-05" @default.
- W2052539116 modified "2023-09-27" @default.
- W2052539116 title "Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilars" @default.
- W2052539116 cites W2001080845 @default.
- W2052539116 cites W2031412005 @default.
- W2052539116 cites W2061308756 @default.
- W2052539116 cites W2078716707 @default.
- W2052539116 cites W2080611602 @default.
- W2052539116 cites W2081561057 @default.
- W2052539116 cites W2105079657 @default.
- W2052539116 cites W2140200788 @default.
- W2052539116 cites W2148639676 @default.
- W2052539116 cites W2162413706 @default.
- W2052539116 cites W2163970022 @default.
- W2052539116 doi "https://doi.org/10.1517/14740338.2015.1001364" @default.
- W2052539116 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25557261" @default.
- W2052539116 hasPublicationYear "2015" @default.
- W2052539116 type Work @default.
- W2052539116 sameAs 2052539116 @default.
- W2052539116 citedByCount "13" @default.
- W2052539116 countsByYear W20525391162015 @default.
- W2052539116 countsByYear W20525391162016 @default.
- W2052539116 countsByYear W20525391162017 @default.
- W2052539116 countsByYear W20525391162018 @default.
- W2052539116 countsByYear W20525391162019 @default.
- W2052539116 crossrefType "journal-article" @default.
- W2052539116 hasAuthorship W2052539116A5002529159 @default.
- W2052539116 hasAuthorship W2052539116A5016491016 @default.
- W2052539116 hasAuthorship W2052539116A5046569565 @default.
- W2052539116 hasAuthorship W2052539116A5063496464 @default.
- W2052539116 hasAuthorship W2052539116A5078134055 @default.
- W2052539116 hasAuthorship W2052539116A5091660415 @default.
- W2052539116 hasConcept C104863432 @default.
- W2052539116 hasConcept C120665830 @default.
- W2052539116 hasConcept C121332964 @default.
- W2052539116 hasConcept C126322002 @default.
- W2052539116 hasConcept C177713679 @default.
- W2052539116 hasConcept C197636746 @default.
- W2052539116 hasConcept C197934379 @default.
- W2052539116 hasConcept C512399662 @default.
- W2052539116 hasConcept C57658597 @default.
- W2052539116 hasConcept C59491497 @default.
- W2052539116 hasConcept C61511704 @default.
- W2052539116 hasConcept C71924100 @default.
- W2052539116 hasConcept C98274493 @default.
- W2052539116 hasConceptScore W2052539116C104863432 @default.
- W2052539116 hasConceptScore W2052539116C120665830 @default.
- W2052539116 hasConceptScore W2052539116C121332964 @default.
- W2052539116 hasConceptScore W2052539116C126322002 @default.
- W2052539116 hasConceptScore W2052539116C177713679 @default.
- W2052539116 hasConceptScore W2052539116C197636746 @default.
- W2052539116 hasConceptScore W2052539116C197934379 @default.
- W2052539116 hasConceptScore W2052539116C512399662 @default.
- W2052539116 hasConceptScore W2052539116C57658597 @default.
- W2052539116 hasConceptScore W2052539116C59491497 @default.
- W2052539116 hasConceptScore W2052539116C61511704 @default.
- W2052539116 hasConceptScore W2052539116C71924100 @default.
- W2052539116 hasConceptScore W2052539116C98274493 @default.
- W2052539116 hasIssue "3" @default.
- W2052539116 hasLocation W20525391161 @default.
- W2052539116 hasLocation W20525391162 @default.
- W2052539116 hasOpenAccess W2052539116 @default.
- W2052539116 hasPrimaryLocation W20525391161 @default.
- W2052539116 hasRelatedWork W2201609171 @default.
- W2052539116 hasRelatedWork W2274594750 @default.
- W2052539116 hasRelatedWork W2519117106 @default.
- W2052539116 hasRelatedWork W2770744592 @default.
- W2052539116 hasRelatedWork W2975989529 @default.
- W2052539116 hasRelatedWork W2980813939 @default.
- W2052539116 hasRelatedWork W3136948945 @default.
- W2052539116 hasRelatedWork W3167063469 @default.
- W2052539116 hasRelatedWork W3204021568 @default.
- W2052539116 hasRelatedWork W3209786888 @default.
- W2052539116 hasVolume "14" @default.
- W2052539116 isParatext "false" @default.
- W2052539116 isRetracted "false" @default.
- W2052539116 magId "2052539116" @default.
- W2052539116 workType "article" @default.